These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 33957167)

  • 1. Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer's disease and insomnia: A systematic review and meta-analysis of randomized controlled trials.
    Sumsuzzman DM; Choi J; Jin Y; Hong Y
    Neurosci Biobehav Rev; 2021 Aug; 127():459-473. PubMed ID: 33957167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.
    Wade AG; Farmer M; Harari G; Fund N; Laudon M; Nir T; Frydman-Marom A; Zisapel N
    Clin Interv Aging; 2014; 9():947-61. PubMed ID: 24971004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Involvement of Melatonin and Tasimelteon against Alzheimer's Disease.
    Ravikumar M; Mohan S; Velpandian C
    Curr Drug Saf; 2023; 18(3):284-296. PubMed ID: 35585820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dose and Duration-dependent Association between Melatonin Treatment and Overall Cognition in Alzheimer's Dementia: A Network Meta- Analysis of Randomized Placebo-Controlled Trials.
    Tseng PT; Zeng BY; Chen YW; Yang CP; Su KP; Chen TY; Wu YC; Tu YK; Lin PY; Carvalho AF; Stubbs B; Matsuoka YJ; Li DJ; Liang CS; Hsu CW; Sun CK; Cheng YS; Yeh PY; Shiue YL
    Curr Neuropharmacol; 2022; 20(10):1816-1833. PubMed ID: 35450525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer's disease.
    Wang YY; Zheng W; Ng CH; Ungvari GS; Wei W; Xiang YT
    Int J Geriatr Psychiatry; 2017 Jan; 32(1):50-57. PubMed ID: 27645169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of melatonin for sleep onset insomnia in children and adolescents: a meta-analysis of randomized controlled trials.
    Wei S; Smits MG; Tang X; Kuang L; Meng H; Ni S; Xiao M; Zhou X
    Sleep Med; 2020 Apr; 68():1-8. PubMed ID: 31982807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin in elderly patients with insomnia. A systematic review.
    Olde Rikkert MG; Rigaud AS
    Z Gerontol Geriatr; 2001 Dec; 34(6):491-7. PubMed ID: 11828891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Yang G; Wang Y; Sun J; Zhang K; Liu J
    Curr Top Med Chem; 2016; 16(5):520-8. PubMed ID: 26268332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer's Disease but Are Not Correlated with Cognitive Decline.
    Nous A; Wittens MMJ; Vermeiren Y; De Deyn PP; Van Broeckhoven C; Nagels G; Smolders I; Engelborghs S
    J Alzheimers Dis; 2021; 83(2):693-704. PubMed ID: 34366353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivastigmine for Alzheimer's disease.
    Birks JS; Grimley Evans J
    Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selegiline for Alzheimer's disease.
    Birks J; Flicker L
    Cochrane Database Syst Rev; 2003; (1):CD000442. PubMed ID: 12535396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin decreases daytime challenging behaviour in persons with intellectual disability and chronic insomnia.
    Braam W; Didden R; Maas AP; Korzilius H; Smits MG; Curfs LM
    J Intellect Disabil Res; 2010 Jan; 54(1):52-9. PubMed ID: 19888921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of melatonin in selected populations of sleep-disturbed patients.
    Brusco LI; Fainstein I; Márquez M; Cardinali DP
    Biol Signals Recept; 1999; 8(1-2):126-31. PubMed ID: 10085474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid with or without vitamin B12 for cognition and dementia.
    Malouf M; Grimley EJ; Areosa SA
    Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N
    BMC Med; 2010 Aug; 8():51. PubMed ID: 20712869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive behavioral therapy for insomnia to enhance cognitive function and reduce the rate of Aβ deposition in older adults with symptoms of insomnia: A single-site randomized pilot clinical trial protocol.
    Siengsukon CF; Nelson E; Williams-Cooke C; Ludwig R; Beck ES; Vidoni ED; Mahnken JD; Stevens S; Drerup M; Bruce J; Burns JM
    Contemp Clin Trials; 2020 Dec; 99():106190. PubMed ID: 33091586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of melatonin in Alzheimer's disease.
    Cardinali DP; Brusco LI; Liberczuk C; Furio AM
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():20-3. PubMed ID: 12019347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological interventions to improve sleep in people with Alzheimer's disease: a meta-analysis of randomized controlled trials.
    Bedward A; Kaur J; Seedat S; Donohue H; Kow CS; Rasheed MK; Javed A; Hasan SS
    Expert Rev Neurother; 2024 May; 24(5):527-539. PubMed ID: 38597219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.